• No results found

Nyrstar - Extraordinary General Shareholders' Meeting to be held on 9 dec (8.11.2019) | Vlaamse Federatie van Beleggers

N/A
N/A
Protected

Academic year: 2022

Share "Nyrstar - Extraordinary General Shareholders' Meeting to be held on 9 dec (8.11.2019) | Vlaamse Federatie van Beleggers"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

1

Regulated Information

Nyrstar: Extraordinary General Shareholders' Meeting of Nyrstar NV to be held on 9 December 2019

8 November 2019 at 07.00 CET

Nyrstar NV (the "Company") today invited the holders of shares issued by the Company to attend an extraordinary general shareholders' meeting (the “Second EGM”) on 9 December 2019, to resolve on the items on the agenda of the extraordinary general shareholders' meeting held on 5 November 2019 (the “First EGM”), as the attendance quorum required for the items on the agenda of the First EGM was not met. The Second EGM will commence at 13:00 CET, at BluePoint, Filip Williostraat 9, 2600 Antwerp, Belgium.

The full notice, including agenda, proposed resolutions and explanatory note, can be found on the Nyrstar website: https://www.nyrstar.be/en/investors/share-and-bondholder-information/shareholder-meetings.

About Nyrstar

The Company is incorporated in Belgium and, following completion of the recapitalisation/restructuring has a 2% shareholding in the Nyrstar group. The Company is listed on Euronext Brussels under the symbol NYR. For further information please visit the Nyrstar website: www.nyrstar.be

For further information contact:

Anthony Simms - Head of Investor Relations T: +41 44 745 8157 M: +41 79 722 2152 anthony.simms@nyrstar.com

Referenties

GERELATEERDE DOCUMENTEN

Dijkhuizen - who was unable to participate in the meeting due to the current COVID-19 travel advice from the Belgian government for the Netherlands – would have expired following

MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any

The Company advises that a set of documents containing confidential (but not inside) information is now also available to current shareholders and bondholders of Nyrstar (the

This Meeting is convened to seek the approval by Bondholders of certain proposed resolutions, in order to facilitate the implementation of the financial restructuring

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' or managements'

Nyrstar today invited its shareholders to attend its forthcoming annual general shareholders’ meeting on 5 November 2019, followed by an extraordinary general

Therefore, a second extraordinary general shareholders' meeting will be convened to be held for the items on the agenda of the EGM on 9 December 2019 at 13:00 CET, in Antwerp..

Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception